Drugs / B. subtilis
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT06612411 Comparator | Jun → Dec 2024 overdue | irritable bowel syndrome, purine metabolism disease | Jinling Hospital, China | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | B. subtilis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06612411 ↗ |
| Route | Oral | “2 capsules, 3 times a day, orally taken for one month” NCT06612411 ↗ |